Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBX5 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | NUS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | SRRD | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | TCF20 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | CDCA8 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | BHLHE41 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | PXMP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | PABPN1 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | IPO5 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | CENPU | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |